177 related articles for article (PubMed ID: 14695827)
1. Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody.
Paula S; Tabet MR; Farr CD; Norman AB; Ball WJ
J Med Chem; 2004 Jan; 47(1):133-42. PubMed ID: 14695827
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional structure-activity relationship modeling of cocaine binding to two monoclonal antibodies by comparative molecular field analysis.
Paula S; Tabet MR; Keenan SM; Welsh WJ; Ball WJ
J Mol Biol; 2003 Jan; 325(3):515-30. PubMed ID: 12498800
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.
Sherman MA; Linthicum DS; Bolger MB
Mol Pharmacol; 1986 Jun; 29(6):589-98. PubMed ID: 2423865
[TBL] [Abstract][Full Text] [Related]
5. Expression and characterization of a humanized cocaine-binding antibody.
Redwan el-RM; Larsen NA; Zhou B; Wirsching P; Janda KD; Wilson IA
Biotechnol Bioeng; 2003 Jun; 82(5):612-8. PubMed ID: 12652485
[TBL] [Abstract][Full Text] [Related]
6. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
7. A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2.
Lape M; Paula S; Ball WJ
Eur J Med Chem; 2010 Jun; 45(6):2291-8. PubMed ID: 20185210
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a cocaine-binding antibody.
Larsen NA; Zhou B; Heine A; Wirsching P; Janda KD; Wilson IA
J Mol Biol; 2001 Aug; 311(1):9-15. PubMed ID: 11469854
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
[TBL] [Abstract][Full Text] [Related]
10. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure.
Cashman JR; Berkman CE; Underiner GE
J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397
[TBL] [Abstract][Full Text] [Related]
11. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
[TBL] [Abstract][Full Text] [Related]
12. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment.
Yuan H; Kozikowski AP; Petukhov PA
J Med Chem; 2004 Dec; 47(25):6137-43. PubMed ID: 15566285
[TBL] [Abstract][Full Text] [Related]
13. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
[TBL] [Abstract][Full Text] [Related]
14. In silico prediction of peptide binding affinity to class I mouse major histocompatibility complexes: a comparative molecular similarity index analysis (CoMSIA) study.
Hattotuwagama CK; Doytchinova IA; Flower DR
J Chem Inf Model; 2005; 45(5):1415-23. PubMed ID: 16180918
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis.
Farr CD; Tabet MR; Ball WJ; Fishwild DM; Wang X; Nair AC; Welsh WJ
J Med Chem; 2002 Jul; 45(15):3257-70. PubMed ID: 12109909
[TBL] [Abstract][Full Text] [Related]
16. A fiber-optic cocaine biosensor.
Devine PJ; Anis NA; Wright J; Kim S; Eldefrawi AT; Eldefrawi ME
Anal Biochem; 1995 May; 227(1):216-24. PubMed ID: 7668383
[TBL] [Abstract][Full Text] [Related]
17. Broad-specificity immunoassay for O,O-diethyl organophosphorus pesticides: application of molecular modeling to improve assay sensitivity and study antibody recognition.
Xu ZL; Shen YD; Zheng WX; Beier RC; Xie GM; Dong JX; Yang JY; Wang H; Lei HT; She ZG; Sun YM
Anal Chem; 2010 Nov; 82(22):9314-21. PubMed ID: 20958019
[TBL] [Abstract][Full Text] [Related]
18. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
Roy K; Leonard JT
J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.
Thaimattam R; Daga P; Rajjak SA; Banerjee R; Iqbal J
Bioorg Med Chem; 2004 Dec; 12(24):6415-25. PubMed ID: 15556759
[TBL] [Abstract][Full Text] [Related]
20. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
